title: Pharmacokinetics of tacrolimus: clinically relevant aspects.
authors.affiliation: Fujisawa GmbH, Munich, Germany.
authors.forename: N A
authors.initials: NA
authors.lastname: Undre
authors.forename: P
authors.initials: P
authors.lastname: Stevenson
authors.forename: A
authors.initials: A
authors.lastname: Schäfer
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005947:Glucose / Q000378:metabolism; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008657:Metabolic Clearance Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced
chemical_list: D007166:Immunosuppressive Agents; D005947:Glucose; D016559:Tacrolimus